Solazyme Inc. (NASDAQ:TVIA) shares traded up 4.6% during trading on Tuesday . The company traded as high as $2.79 and last traded at $2.74, with a volume of 373,968 shares changing hands. The stock had previously closed at $2.62.

The firm’s market cap is $229.24 million. The company’s 50-day moving average price is $2.50 and its 200-day moving average price is $2.19.

Solazyme (NASDAQ:TVIA) last issued its earnings results on Monday, August 8th. The company reported ($0.26) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.29) by $0.03. The firm earned $9.90 million during the quarter, compared to analyst estimates of $10.85 million. During the same quarter in the previous year, the business posted $0.40 EPS. Solazyme’s revenue was down 15.4% compared to the same quarter last year. Analysts forecast that Solazyme Inc. will post ($1.15) earnings per share for the current year.

In related news, CFO Tyler Painter sold 12,500 shares of Solazyme stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $2.67, for a total value of $33,375.00. Following the transaction, the chief financial officer now owns 400,337 shares in the company, valued at $1,068,899.79. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.